TransAct Technologies Completes $9.8 Million Public Offering of Common Stock, Including Full Exercise of Overallotment Option

HAMDEN, Conn.–(BUSINESS WIRE)–Oct 16, 2020–

TransAct Applied sciences Included (Nasdaq:TACT) (“TransAct,” the “Firm,” “we” or “our”), a worldwide chief in software-driven know-how and printing options for high-growth markets, at the moment introduced the closing of an underwritten public providing of 1,380,000 newly issued shares of its widespread inventory, together with 180,000 shares bought on account of the train in stuffed with the overallotment choice granted to the underwriters, at a beforehand disclosed value of $7.10 per share. The proceeds to the Firm from the providing had been roughly $9.8 million earlier than deducting underwriting reductions and commissions and estimated providing bills payable by the Firm.

Roth Capital Companions acted as the only book-running supervisor for the providing, and Barrington Analysis Associates, Inc. acted as co-manager for the providing.

TransAct intends to make use of the online proceeds from the providing for working capital and different common company functions, which can embody funding the additional improvement of TransAct’s meals service know-how enterprise and associated gross sales, advertising and marketing and product improvement efforts, know-how enhancements and personnel prices in assist of TransAct’s development technique.

A shelf registration assertion regarding the shares of widespread inventory issued within the providing was filed with the Securities and Alternate Fee (the “SEC”) on August 17, 2020 and is efficient. This press launch shall not represent a proposal to promote or the solicitation of a proposal to purchase any of the securities described herein, nor shall there be any sale of those securities in any state or jurisdiction through which such provide, solicitation or sale could be illegal previous to registration or qualification beneath the securities legal guidelines of any such state or jurisdiction. A last prospectus complement and accompanying base prospectus regarding and describing the ultimate phrases of the providing have been filed with the SEC and could also be obtained from Roth Capital Companions, LLC, 888 San Clemente, Newport Seaside, CA 92660, by electronic mail at rothecm@roth.com or by phone at (800) 678-9147, or by accessing the SEC’s web site, www.sec.gov.

About TransAct Applied sciences Included

TransAct Applied sciences Included is a worldwide chief in growing software-driven know-how and printing options for high-growth markets together with meals service, on line casino and gaming, POS automation, and oil and fuel. The Firm’s options are designed from the bottom up based mostly on buyer necessities and are bought beneath the BOHA! ™, AccuDate™, EPICENTRAL®, Epic®, Ithaca® and Printrex® manufacturers. TransAct has bought over 3.4 million printers and terminals world wide and is dedicated to offering world-class service, spare elements and equipment to assist its put in product base. By way of the TransAct Companies Group, the Firm additionally gives prospects with an entire vary of provides and consumable gadgets each on-line at http://www.transactsupplies.com and thru its direct gross sales staff. TransAct is headquartered in Hamden, CT. For extra info, please go to http://www.transact-tech.com or name (203) 859-6800.

Ahead-Trying Statements

Sure statements on this press launch embody forward-looking statements. Ahead-looking statements typically might be recognized by means of forward-looking terminology, comparable to “might,” “will,” “anticipate,” “intend,” “estimate,” “anticipate,” “consider,” “mission,” “plan” or “proceed,” or the detrimental thereof, or different related phrases. All forward-looking statements contain dangers and uncertainties, together with, however not restricted to, the hostile impact of the COVID-19 pandemic on our enterprise, operations, monetary situation, outcomes of operations and capital sources, together with on account of provide chain disruptions, shutdowns and/or operational restrictions imposed on our prospects, lack of ability of our prospects to make funds on time or in any respect, diversion of administration consideration, mandatory modifications to our enterprise practices and operations, price reducing measures we’ve made and will proceed to make, a doable future discount within the worth of goodwill or different intangible property, insufficient manufacturing capability or a shortfall or extra of stock on account of problem in predicting manufacturing necessities on account of unstable financial circumstances, value will increase or decreased availability of part elements or uncooked supplies, alternate fee fluctuations, volatility of and reduces in buying and selling costs of our widespread inventory and the provision of wanted financing on acceptable phrases or in any respect; our capacity to efficiently develop new merchandise that garner buyer acceptance and generate gross sales, each domestically and internationally, within the face of considerable competitors from rivals which have broader traces of merchandise and higher monetary sources; our capacity to efficiently transition our enterprise into the meals service know-how market; our capacity to remediate the fabric weaknesses over inside management over monetary reporting; dangers related to potential future acquisitions; common financial circumstances in america, Australia, Europe and Asia; our dependence on contract producers for the manufacturing and meeting of a big portion of our merchandise in Asia; our dependence on important suppliers; our capacity to recruit and retain high quality staff because the Firm grows; our dependence on third events for gross sales exterior america, together with in Australia and Asia; market acceptance of latest merchandise; dangers related to international operations; the provision of third-party parts at cheap costs; value wars or different important pricing pressures affecting the Firm’s merchandise in america or overseas; elevated product prices or diminished buyer demand for our merchandise on account of adjustments in U.S. coverage which will lead to commerce wars or tariffs; our capacity to guard mental property; the impact on international financial circumstances, monetary markets and our enterprise from the UK’s withdrawal from the European Union; and different danger components detailed within the Firm’s annual report on Kind 10-Ok for the yr ended December 31, 2019, quarterly stories for the quarters ended March 31, 2020 and June 30, 2020, and different stories filed with the SEC. Precise outcomes might differ materially from these mentioned in, or implied by, the forward-looking statements. The forward-looking statements communicate solely as of the date of this launch, and the Firm assumes no responsibility to replace them to replicate new, altering or unanticipated occasions or circumstances, besides as required by relevant regulation.

View supply model on businesswire.com:https://www.businesswire.com/news/home/20201016005525/en/

CONTACT: Buyers:

Bart Shuldman

Chairman and Chief Govt Officer

TransAct Applied sciences Included

702-388-8180

Michael Bowen

ICR, Inc.

Michael.Bowen@icrinc.com

203-682-8299

Marc P. Griffin

ICR, Inc.